Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS)
CNY 220.76
(0.79%)
CNY 220.76
(0.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.23 Billion | 6.87 Billion | 462.27 Million | 1.46 Billion | -879.37 Million | 612.31 Million |
| Net Income | 2.79 Billion | 2.52 Billion | 2.46 Billion | 1.68 Billion | 1.38 Billion | 1.12 Billion |
| Depreciation & Amortization | 128.69 Million | 80.35 Million | 133.49 Million | 90.21 Million | 55.88 Million | 60.46 Million |
| Deferred income taxes | -51.3 Million | 9.34 Million | -58.22 Million | -12.64 Million | -8.43 Million | -19.76 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -634.27 Million | 4.27 Billion | -2.17 Billion | -270.07 Million | -2.35 Billion | -547.83 Million |
| Other non-cash items | 881.94 Million | -3.07 Million | 40.67 Million | -42.41 Million | 27.82 Million | -29.04 Million |
| Investing Cash Flow | -2.79 Billion | -6.3 Billion | 78.28 Million | -282.02 Million | 67.83 Million | 65.08 Million |
| Investments in PPE | -141.87 Million | -175.37 Million | -92.16 Million | -419.01 Million | -65.43 Million | -74.23 Million |
| Acquisitions | 869.86 Thousand | 35.18 Million | 20.69 Million | -1.91 Million | 13.17 Million | - |
| Investment purchases | -8.94 Billion | -58.54 Million | -9.49 Million | -14.15 Million | -961.85 Thousand | -54.22 Million |
| Sales/Maturities of investments | 6.29 Billion | 45.43 Million | 174.64 Million | 66.85 Million | 61.72 Million | 69.49 Million |
| Other Investing Activities | -2.66 Billion | -6.15 Billion | -15.38 Million | 86.19 Million | 59.33 Million | 124.05 Million |
| Financing Cash Flow | -768.91 Million | -575.81 Million | -540.22 Million | -536.51 Million | 404.89 Million | -116.11 Million |
| Debt repayment | -56.45 Million | -1.39 Billion | -1.35 Billion | -1.06 Billion | -1.06 Billion | -667.4 Million |
| Dividends payments | -754.14 Million | -730.01 Million | -542.98 Million | -494.72 Million | -361.57 Million | -284.23 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -32.62 Million | 1.58 Billion | 1.38 Billion | 1.04 Billion | 1.86 Billion | 835.51 Million |
| Accounts receivables | -181.92 Million | 4.25 Billion | -2.08 Billion | -222.1 Million | -2.07 Billion | -186.64 Million |
| Accounts payables | 306.42 Million | 205.02 Million | 232.58 Million | 39.54 Million | 160.97 Million | 93.22 Million |
| Inventory | -758.77 Million | -199.38 Million | -261.56 Million | -74.87 Million | -429.55 Million | -434.65 Million |
| Other working capital | 255.12 Million | 9.34 Million | -58.22 Million | -12.64 Million | -8.43 Million | -113.17 Million |
| Cash at beginning of period | 2.42 Billion | 2.4 Billion | 2.41 Billion | 1.76 Billion | 2.17 Billion | 1.6 Billion |
| Cash at end of period | 1.08 Billion | 2.41 Billion | 2.4 Billion | 2.41 Billion | 1.76 Billion | 2.17 Billion |
| Capital Expenditure | -141.87 Million | -175.37 Million | -92.16 Million | -419.01 Million | -65.43 Million | -74.23 Million |
| Effect of forex changes on cash | 2.42 Million | 11.43 Million | -4.62 Million | -6.26 Million | 4.86 Million | 8.23 Million |
| Net cash flow / Change in cash | -1.33 Billion | 3.84 Million | -4.29 Million | 642.26 Million | -401.77 Million | 569.5 Million |
| Free Cash Flow | 2.08 Billion | 6.69 Billion | 370.1 Million | 1.04 Billion | -944.8 Million | 538.07 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 965.14 Million | 747.03 Million | 974.5 Million | 392.7 Million | 2.79 Billion | 863.81 Million |
| Depreciation & Amortization | - | 26.36 Million | 26.36 Million | 36.91 Million | 128.69 Million | -47.64 Million |
| Deferred income taxes | - | -5.25 Million | - | - | -51.3 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -973.87 Million | - | -940.7 Million | -634.27 Million | -35.84 Million |
| Other non-cash items | -38.68 Million | -864.8 Million | -443.02 Million | -516.56 Million | 881.94 Million | 230.6 Million |
| Investing Cash Flow | -6.51 Billion | 8.18 Billion | 592.18 Million | -1.47 Billion | -2.79 Billion | -353.68 Million |
| Investments in PPE | -33.52 Million | -15.02 Million | -27.43 Million | -42.54 Million | -141.87 Million | -18.92 Million |
| Acquisitions | 126.03 Thousand | 5.51 Million | 758.38 Thousand | 26.94 Thousand | 869.86 Thousand | 230.38 Thousand |
| Investment purchases | -10.69 Million | -89.31 Million | - | -8.94 Billion | -8.94 Billion | 56.88 Thousand |
| Sales/Maturities of investments | 9.06 Million | 8.9 Billion | - | 6.29 Billion | 6.29 Billion | 6.39 Million |
| Other Investing Activities | -6.48 Billion | -618.85 Million | 618.85 Million | 1.22 Billion | -2.66 Billion | -341.44 Million |
| Financing Cash Flow | -56.18 Million | -1.48 Billion | 89.43 Million | 164.65 Million | -768.91 Million | -835.94 Million |
| Debt repayment | -35.14 Million | -61.31 Million | -104.29 Million | -187.77 Million | -56.45 Million | -176.42 Million |
| Dividends payments | -6.7 Million | -1.4 Billion | -8.23 Million | -754.14 Million | -754.14 Million | -761.62 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -14.33 Million | -1.4 Billion | -14.85 Million | 769.63 Million | -32.62 Million | 102.09 Million |
| Accounts receivables | - | 193.77 Million | - | -181.92 Million | -181.92 Million | 25.31 Million |
| Accounts payables | - | - | - | - | 306.42 Million | - |
| Inventory | - | -1.16 Billion | - | -758.77 Million | -758.77 Million | -61.15 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 8.84 Billion | 2.37 Billion | 1.08 Billion | 2.63 Billion | 2.42 Billion | 2.72 Billion |
| Cash at end of period | 3.19 Billion | 8.84 Billion | 2.37 Billion | 1.08 Billion | 1.08 Billion | 2.55 Billion |
| Capital Expenditure | -33.52 Million | -15.02 Million | -27.43 Million | -42.54 Million | -141.87 Million | -18.92 Million |
| Effect of forex changes on cash | -1.24 Million | 4.19 Million | 2.9 Million | -2.47 Million | 2.42 Million | 533.72 Thousand |
| Net cash flow / Change in cash | -5.65 Billion | 6.47 Billion | 1.28 Billion | -1.54 Billion | -1.33 Billion | -178.17 Million |
| Free Cash Flow | 892.94 Million | -164.41 Million | 504.05 Million | -203.31 Million | 2.08 Billion | 991.99 Million |
600379
BWB
PGTK
ECC-B
GTCH
TWLO